The blood transfusion devices market size has grown strongly in recent years. It will grow from $5.45 billion in 2025 to $5.84 billion in 2026 at a compound annual growth rate (CAGR) of 7%. The growth in the historic period can be attributed to reliance on manual blood transfusion methods, limited access to advanced pathogen reduction systems, increasing number of surgical procedures, rising hospital and blood bank infrastructures, growing awareness of transfusion safety.
The blood transfusion devices market size is expected to see strong growth in the next few years. It will grow to $7.55 billion in 2030 at a compound annual growth rate (CAGR) of 6.7%. The growth in the forecast period can be attributed to technological advancements in automated apheresis and component separators, increasing demand for minimally invasive surgical procedures, expansion of blood bank networks, rising regulatory standards for transfusion devices, integration of smart monitoring and digital tracking in transfusion systems. Major trends in the forecast period include rising adoption of automated blood component separation systems, increasing use of pathogen reduction technologies, expansion of blood bag and accessory innovations, growth in specialized venous access devices, rising demand for blood storage and transfusion equipment.
The rise in accidents and trauma cases is expected to propel the growth of the blood transfusion devices market going forward. Accidents and trauma cases are increasing due to rapid urbanization, higher vehicle usage, and unsafe road conditions. Blood transfusion devices are crucial in trauma and accident scenarios, as they enable the rapid administration of life-saving blood products to stabilize patients and manage severe bleeding. For instance, in July 2024, according to the National Safety Council Injury Facts, a US-based safety organization, motor vehicle fatalities in the United States reached 20,900 during the first half of 2024, remaining nearly unchanged from 20,930 fatalities recorded during the same period in 2023, despite a 0.8% increase in mileage from 2023 and a 3.1% rise from 2022. Therefore, the increasing number of accidents and trauma cases is driving the growth of the blood transfusion devices market.
Leading companies operating in the blood transfusion devices market are focusing on developing advanced blood grouping and testing solutions to strengthen their competitive position. Blood grouping and testing solutions include medical devices and reagents used to determine blood type and ensure transfusion compatibility. For example, in June 2024, Innobiochips, a France-based biopharmaceutical company, launched Omnys, an innovative blood transfusion device designed to improve laboratory productivity and accuracy through multiplex analysis. The system enables high-resolution testing of blood components, including standard ABO/D typing and extended phenotyping, while reducing the number of testing wells required and minimizing waste.
In March 2023, Werfen S.A., a Spain-based biomaterials manufacturer, acquired Immucor Inc. for $2 billion. This acquisition strengthens Werfen’s position in the transfusion and transplant markets while expanding its portfolio across hemostasis, acute care, and autoimmunity. Immucor Inc. is a US-based provider of blood transfusion devices.
Major companies operating in the blood transfusion devices market are BAG Health Care GmbH, Grifols S.A., Bio-Rad Laboratories Inc., Abbott Laboratories, Immucor Inc., Ortho Clinical Diagnostics, Siemens Healthineers, Beckman Coulter Inc., Diagast SAS, QuidelOrtho Corporation, Danaher Corporation, Becton Dickinson and Company, Quotient Biodiagnostics, Sysmex Corporation, HemoCue AB, Agena Bioscience Inc., Tulip Diagnostics P Ltd, Merck KGaA, Trinity Biotech, MTC Med Testconsult GmbH, BioMedomics Inc, Agappe Diagnostics Ltd, Day Medical SA.
North America was the largest region in the blood transfusion devices market in 2025. The regions covered in the blood transfusion devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the blood transfusion devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the blood transfusion devices market by increasing costs for imported components such as automated separators, pathogen reduction systems, and specialized blood bags. Segments like blood component separators and venous access devices are particularly affected, with regions like Asia-Pacific, including China and India, facing higher import duties. This has resulted in elevated production costs and supply chain adjustments. However, tariffs have also encouraged local manufacturing, innovation in cost-effective device alternatives, and investment in domestic production capabilities.
The blood transfusion devices market research report is one of a series of new reports that provides blood transfusion devices market statistics, including blood transfusion devices industry global market size, regional shares, competitors with a blood transfusion devices market share, detailed blood transfusion devices market segments, market trends and opportunities, and any further data you may need to thrive in the blood transfusion devices industry. This blood transfusion devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Blood transfusion devices are medical tools and systems used to safely transfer blood or blood components - such as red cells, plasma, or platelets - from a donor to a patient. They play a vital role in surgeries, trauma care, and the treatment of conditions like anemia and clotting disorders.
The major product categories of blood transfusion devices include pathogen reduction systems, apheresis devices, blood component separators, blood bags and accessories, venous access devices, and others. A pathogen reduction system is a technology designed to minimize or eliminate pathogens from blood products to enhance transfusion safety. The applications include cardiovascular, orthopedic, neurological, obstetric, and gynecological surgeries, among others, and these devices are used by end users such as hospitals, ambulatory surgical centers, blood banks, and others.
The blood transfusion devices market consists of sales of blood warmers, needles, catheters, and filters. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The blood transfusion devices market size is expected to see strong growth in the next few years. It will grow to $7.55 billion in 2030 at a compound annual growth rate (CAGR) of 6.7%. The growth in the forecast period can be attributed to technological advancements in automated apheresis and component separators, increasing demand for minimally invasive surgical procedures, expansion of blood bank networks, rising regulatory standards for transfusion devices, integration of smart monitoring and digital tracking in transfusion systems. Major trends in the forecast period include rising adoption of automated blood component separation systems, increasing use of pathogen reduction technologies, expansion of blood bag and accessory innovations, growth in specialized venous access devices, rising demand for blood storage and transfusion equipment.
The rise in accidents and trauma cases is expected to propel the growth of the blood transfusion devices market going forward. Accidents and trauma cases are increasing due to rapid urbanization, higher vehicle usage, and unsafe road conditions. Blood transfusion devices are crucial in trauma and accident scenarios, as they enable the rapid administration of life-saving blood products to stabilize patients and manage severe bleeding. For instance, in July 2024, according to the National Safety Council Injury Facts, a US-based safety organization, motor vehicle fatalities in the United States reached 20,900 during the first half of 2024, remaining nearly unchanged from 20,930 fatalities recorded during the same period in 2023, despite a 0.8% increase in mileage from 2023 and a 3.1% rise from 2022. Therefore, the increasing number of accidents and trauma cases is driving the growth of the blood transfusion devices market.
Leading companies operating in the blood transfusion devices market are focusing on developing advanced blood grouping and testing solutions to strengthen their competitive position. Blood grouping and testing solutions include medical devices and reagents used to determine blood type and ensure transfusion compatibility. For example, in June 2024, Innobiochips, a France-based biopharmaceutical company, launched Omnys, an innovative blood transfusion device designed to improve laboratory productivity and accuracy through multiplex analysis. The system enables high-resolution testing of blood components, including standard ABO/D typing and extended phenotyping, while reducing the number of testing wells required and minimizing waste.
In March 2023, Werfen S.A., a Spain-based biomaterials manufacturer, acquired Immucor Inc. for $2 billion. This acquisition strengthens Werfen’s position in the transfusion and transplant markets while expanding its portfolio across hemostasis, acute care, and autoimmunity. Immucor Inc. is a US-based provider of blood transfusion devices.
Major companies operating in the blood transfusion devices market are BAG Health Care GmbH, Grifols S.A., Bio-Rad Laboratories Inc., Abbott Laboratories, Immucor Inc., Ortho Clinical Diagnostics, Siemens Healthineers, Beckman Coulter Inc., Diagast SAS, QuidelOrtho Corporation, Danaher Corporation, Becton Dickinson and Company, Quotient Biodiagnostics, Sysmex Corporation, HemoCue AB, Agena Bioscience Inc., Tulip Diagnostics P Ltd, Merck KGaA, Trinity Biotech, MTC Med Testconsult GmbH, BioMedomics Inc, Agappe Diagnostics Ltd, Day Medical SA.
North America was the largest region in the blood transfusion devices market in 2025. The regions covered in the blood transfusion devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the blood transfusion devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the blood transfusion devices market by increasing costs for imported components such as automated separators, pathogen reduction systems, and specialized blood bags. Segments like blood component separators and venous access devices are particularly affected, with regions like Asia-Pacific, including China and India, facing higher import duties. This has resulted in elevated production costs and supply chain adjustments. However, tariffs have also encouraged local manufacturing, innovation in cost-effective device alternatives, and investment in domestic production capabilities.
The blood transfusion devices market research report is one of a series of new reports that provides blood transfusion devices market statistics, including blood transfusion devices industry global market size, regional shares, competitors with a blood transfusion devices market share, detailed blood transfusion devices market segments, market trends and opportunities, and any further data you may need to thrive in the blood transfusion devices industry. This blood transfusion devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Blood transfusion devices are medical tools and systems used to safely transfer blood or blood components - such as red cells, plasma, or platelets - from a donor to a patient. They play a vital role in surgeries, trauma care, and the treatment of conditions like anemia and clotting disorders.
The major product categories of blood transfusion devices include pathogen reduction systems, apheresis devices, blood component separators, blood bags and accessories, venous access devices, and others. A pathogen reduction system is a technology designed to minimize or eliminate pathogens from blood products to enhance transfusion safety. The applications include cardiovascular, orthopedic, neurological, obstetric, and gynecological surgeries, among others, and these devices are used by end users such as hospitals, ambulatory surgical centers, blood banks, and others.
The blood transfusion devices market consists of sales of blood warmers, needles, catheters, and filters. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Blood Transfusion Devices Market Characteristics
3. Blood Transfusion Devices Market Supply Chain Analysis
4. Global Blood Transfusion Devices Market Trends and Strategies
5. Blood Transfusion Devices Market Analysis of End Use Industries
7. Global Blood Transfusion Devices Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Blood Transfusion Devices Total Addressable Market (TAM) Analysis for the Market
9. Blood Transfusion Devices Market Segmentation
10. Blood Transfusion Devices Market Regional and Country Analysis
11. Asia-Pacific Blood Transfusion Devices Market
12. China Blood Transfusion Devices Market
13. India Blood Transfusion Devices Market
14. Japan Blood Transfusion Devices Market
15. Australia Blood Transfusion Devices Market
16. Indonesia Blood Transfusion Devices Market
17. South Korea Blood Transfusion Devices Market
18. Taiwan Blood Transfusion Devices Market
19. South East Asia Blood Transfusion Devices Market
20. Western Europe Blood Transfusion Devices Market
21. UK Blood Transfusion Devices Market
22. Germany Blood Transfusion Devices Market
23. France Blood Transfusion Devices Market
24. Italy Blood Transfusion Devices Market
25. Spain Blood Transfusion Devices Market
26. Eastern Europe Blood Transfusion Devices Market
27. Russia Blood Transfusion Devices Market
28. North America Blood Transfusion Devices Market
29. USA Blood Transfusion Devices Market
30. Canada Blood Transfusion Devices Market
31. South America Blood Transfusion Devices Market
32. Brazil Blood Transfusion Devices Market
33. Middle East Blood Transfusion Devices Market
34. Africa Blood Transfusion Devices Market
36. Blood Transfusion Devices Market Competitive Landscape and Company Profiles
37. Blood Transfusion Devices Market Other Major and Innovative Companies
40. Blood Transfusion Devices Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Blood Transfusion Devices Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses blood transfusion devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for blood transfusion devices? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The blood transfusion devices market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product Type: Pathogen Reduction System; Apheresis Devices; Blood Component Separator; Blood Bag And Accessory; Venous Access Devices; Other Product Types2) By Application: Cardiovascular Surgeries; Orthopedic Surgeries; Neurological Surgeries; Obstetrics And Gynecological Surgeries; Other Applications
3) By End User: Hospital; Ambulatory Surgical Centers; Blood Bank; Other End Users
Subsegments:
1) By Pathogen Reduction System: Plasma Pathogen Reduction Devices; Platelet Pathogen Reduction Devices2) By Apheresis Devices: Plasma Apheresis Devices; Platelet Apheresis Devices; Red Blood Cell Apheresis Devices
3) By Blood Component Separator: Automated Blood Component Separators; Manual Blood Component Separators
4) By Blood Bag and Accessory: Single Blood Bags; Double Blood Bags; Triple Blood Bags; Quadruple Blood Bags; Blood Bag Tubing and Clamps
5) By Venous Access Devices: Peripheral Venous Catheters; Central Venous Catheters; Peripherally Inserted Central Catheters (PICCs); Implantable Ports
6) By Other Product Types: Blood Warmers; Blood Mixers; Blood Transfusion Sets and Filters; Blood Storage And Refrigeration Systems
Companies Mentioned: BAG Health Care GmbH; Grifols S.A.; Bio-Rad Laboratories Inc.; Abbott Laboratories; Immucor Inc.; Ortho Clinical Diagnostics; Siemens Healthineers; Beckman Coulter Inc.; Diagast SAS; QuidelOrtho Corporation; Danaher Corporation; Becton Dickinson and Company; Quotient Biodiagnostics; Sysmex Corporation; HemoCue AB; Agena Bioscience Inc.; Tulip Diagnostics P Ltd; Merck KGaA; Trinity Biotech; MTC Med Testconsult GmbH; BioMedomics Inc; Agappe Diagnostics Ltd; Day Medical SA
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Blood Transfusion Devices market report include:- BAG Health Care GmbH
- Grifols S.A.
- Bio-Rad Laboratories Inc.
- Abbott Laboratories
- Immucor Inc.
- Ortho Clinical Diagnostics
- Siemens Healthineers
- Beckman Coulter Inc.
- Diagast SAS
- QuidelOrtho Corporation
- Danaher Corporation
- Becton Dickinson and Company
- Quotient Biodiagnostics
- Sysmex Corporation
- HemoCue AB
- Agena Bioscience Inc.
- Tulip Diagnostics P Ltd
- Merck KGaA
- Trinity Biotech
- MTC Med Testconsult GmbH
- BioMedomics Inc
- Agappe Diagnostics Ltd
- Day Medical SA
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 5.84 Billion |
| Forecasted Market Value ( USD | $ 7.55 Billion |
| Compound Annual Growth Rate | 6.7% |
| Regions Covered | Global |
| No. of Companies Mentioned | 24 |
